Triglyceride-glucose index, renal function and cardiovascular disease: a national cohort study

Cancan Cui1, Lin Liu1, Te Zhang1

  • 1China-Japan Union Hospital of Jilin University, Jilin University, Changchun, China.

Cardiovascular Diabetology
|November 29, 2023
PubMed

Insights

The triglyceride-glucose (TyG) index and impaired renal function significantly increase cardiovascular disease risk. Renal function partially mediates the link between the TyG index and cardiovascular events.

Area of Science:

  • Cardiovascular Medicine
  • Nephrology
  • Metabolic Syndrome

Background:

  • The triglyceride-glucose (TyG) index is an emerging marker for cardiovascular disease (CVD) risk.
  • The role of renal function in the association between the TyG index and CVD remains unclear.

Purpose of the Study:

  • To investigate the combined association of the TyG index and renal function with CVD.
  • To evaluate the mediating role of renal function in the TyG index-CVD relationship.

Main Methods:

  • Cohort study utilizing data from the China Health and Retirement Longitudinal Study (CHARLS).
  • Participants were free of CVD at baseline.
  • Triglyceride-glucose (TyG) index calculated as Ln [fasting triglyceride (mg/dL) × fasting glucose (mg/dL)/2].
  • Renal function assessed by estimated glomerular filtration rate (eGFR).
  • Cox regression and mediation analyses were performed.

Main Results:

  • A total of 6,496 participants were analyzed.
  • Higher TyG index and lower eGFR were independently associated with increased CVD risk.
  • The combination of a high TyG index and low eGFR showed the highest CVD risk (HR, 1.870).
  • Decreased eGFR significantly mediated 29.6% of the association between the TyG index and CVD.

Conclusions:

  • Elevated TyG index and impaired renal function synergistically increase cardiovascular disease risk.
  • Renal function plays a significant mediating role in the relationship between the TyG index and cardiovascular risk.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
165
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
96
Glucose Transporters01:27

Glucose Transporters

Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
22.8K